{"product_id":"harvard-psychopharmacology-2025-a-master-class","title":"Harvard Psychopharmacology 2025: A Master Class","description":"\u003cdiv class=\"prod-desc\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003cdiv class=\"bundle--hms_paragraph_with_feature paragraph paragraph--type--hms-paragraph-with-feature paragraph--view-mode--default row\"\u003e\n\u003cdiv class=\"columns small-12 medium-8 large-9 medium-order-2\"\u003e\n\u003cdiv class=\"field field--name-field-hms-pwf-paragraphs field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch3\u003eHarvard Psychopharmacology 2025: A Master Class\u003c\/h3\u003e\n\u003ch3 class=\"component-title field__item\"\u003e2025 Course Overview\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cbr\u003e\u003cbr\u003eWe are pleased to offer our 14th annual two-day Master Class uniquely designed for practicing clinicians, clinical researchers, and trainees in psychiatry. Presentations will focus on typical psychiatric patients with emphasis on those who are difficult to treat or are treatment resistant. Newer treatments and developing treatment strategies will be discussed including the use of genetic tests, blood level measurements, and drug combinations. New research that can inform clinical practice will be emphasized.\u003cbr\u003e\u003cbr\u003eThis conference will focus on the following topics: An updated review of neurobiology and brain function taking the attendee through neurotransmission sequence from the central role of neurotransmitter circuits, transmitters and receptors, synaptic function gene transcription, and interaction between genes and the environment. Drug treatment of schizophrenia and bipolar disorder will be presented with a focus on prodromal symptoms and first episode patients, as well as long-term maintenance, and treatment resistant patients.\u003cbr\u003e\u003cbr\u003eNew antipsychotic medications and treatment augmentation will be reviewed along with potential new uses for mood stabilizers. Neurobiological mechanisms of depression with a discussion of both the genetic and epigenetic contribution, and the role of inflammation will be highlighted. Modern use of antidepressants will be based on the latest clinical findings. Special consideration will be given to ketamine, ECT, TMS, psychedelics, and augmentation strategies for treatment resistant depression, and bipolar depression.\u003cbr\u003e\u003cbr\u003eDiagnosis and treatment of anxiety, and anxiety-spectrum disorders as well as their pharmacological treatment will be presented, including panic disorder, social anxiety disorder, and generalized anxiety disorder, along with recent data regarding the risks and benefits of benzodiazepines. The etiology and standard pharmacological treatment of PTSD will be discussed including the new use of ketamine and psychedelics in a separate presentation.\u003cbr\u003e\u003cbr\u003eThe evaluation and psychopharmacological treatment of women’s mental health issues will be updated with particular emphasis on PMS, perinatal, and postpartum disorders. The course will also include a review of the neurobiology and treatment of sleep disorders in psychiatry as well as a lecture on the neurobiology and treatment of alcohol, cannabis, and other substance abuse disorders. Basic neurobiological and pharmacological factors in the treatment of child and adolescent affective disorders,, and latest advances in geriatric psychopharmacology and neuropsychiatry will be reviewed.\u003cbr\u003e\u003cbr\u003eThe latest advances in the diagnosis and pharmacological treatment of autism spectrum disorders will be presented for the first time in this Master Class series.\u003cbr\u003e\u003cbr\u003eThroughout the course both the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications as well as new neurobiological research findings that will influence clinical practice.\u003cbr\u003e\u003ch3 class=\"variant-1\"\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePsychiatrists and other Physicians\u003c\/li\u003e\n\u003cli\u003ePharmacists\u003c\/li\u003e\n\u003cli\u003eNurse Practitioners\u003c\/li\u003e\n\u003cli\u003ePhysician Assistants\u003c\/li\u003e\n\u003cli\u003eNurses\u003c\/li\u003e\n\u003cli\u003ePsychologists\u003c\/li\u003e\n\u003cli\u003eSocial Workers\u003c\/li\u003e\n\u003cli\u003eMedical students, residents and other trainees\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"variant-1\"\u003eLearning Objectives\u003c\/h3\u003e\n\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEvaluate the effects of neurotransmitters, neurocircuits, and genes on psychotropic drug treatment.\u003c\/li\u003e\n\u003cli\u003eDescribe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode.\u003c\/li\u003e\n\u003cli\u003eOutline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress, and anxiety, PTSD, and neuropsychiatric disorders.\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of psychopharmacology in the management of depression and bipolar disorder in childhood and adolescence.\u003c\/li\u003e\n\u003cli\u003eIdentify the benefits and risks of ketamine and psychedelics, including use for PTSD.\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period.\u003c\/li\u003e\n\u003cli\u003eExplain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis.\u003c\/li\u003e\n\u003cli\u003eGive examples of the latest advances and problems associated with treatment approaches in the geriatric populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-4 large-3 medium-order-1\"\u003e\n\u003cdiv class=\"field field--name-field-hms-pwf-feature-components field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"bundle--hms_feature_component paragraph paragraph--type--hms-feature-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_paragraph_with_layout paragraph paragraph--type--hms-paragraph-with-layout paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 large-9 large-offset-3\"\u003e\n\u003cdiv class=\"accordion-container\"\u003e\n\u003cdiv class=\"bundle--accordions paragraph paragraph--type--accordions paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"accordions columns small-12\"\u003e\n\u003cdiv class=\"accordion\" data-accordion=\"hgflca-accordion\" data-allow-all-closed=\"true\" data-multi-expand=\"true\"\u003e\n\u003cdiv class=\"accordion-item item-1\" data-accordion-item=\"\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-9 large-10 accordion--head\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch2 class=\"component-title field__item\"\u003e2025 Agenda\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cbr\u003e\u003cbr\u003eAll agenda sessions are in Eastern Time.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--title field field--name-field-hms-pdl-title field--type-string field--label-hidden field__items\"\u003e\n\u003ch4 class=\"field__item\"\u003eFriday, March 28, 2025\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--items field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 hms-program-details-list--term\"\u003eDay One\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e7:30-8:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eRegistration\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:00-8:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eWelcome Remarks\u003c\/strong\u003e\u003cbr\u003eCarl Salzman, MD; Matcheri Keshavan, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:15-9:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eUpdate on the Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance\u003c\/strong\u003e\u003cbr\u003eMatcheri Keshavan, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:00-9:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eTreatment-Resistant Depression: Update on New Antidepressants, Polypharmacy, Augmentation Strategies, Ketamine, Psychedelics, and ECT \u003c\/strong\u003e\u003cbr\u003eAlan Schatzberg, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:45-10:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eTreatment of Bipolar Disorders; Neurobiology and Clinical Directions; Revival of Lithium\u003c\/strong\u003e\u003cbr\u003eRoscoe Brady, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30-10:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:45-11:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eUpdate: The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause\u003c\/strong\u003e\u003cbr\u003eKristina Deligiannidis, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:30 AM-12:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePsychopharmacologic Approaches in Childhood Affective Disorders\u003c\/strong\u003e\u003cbr\u003eMelissa Delbello, MD, MS\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:15-12:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePanel Discussion #1\u003c\/strong\u003e\u003cbr\u003eRoscoe Brady, MD; Matcheri Keshavan, MD; Alan Schatzberg, MD; Kristina Deligiannidis, MD; Melissa Delbello, MD, MS\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:45-1:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eLunch \u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45-2:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eClinical Relevance of Brain Circuity for Psychiatric Treatment\u003c\/strong\u003e\u003cbr\u003eRoscoe Brady, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:30-3:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePsychopharmacology in Geriatrics and Neuropsychiatry\u003c\/strong\u003e\u003cbr\u003eAlejandro (Danny) Mendoza, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:15-3:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:30-4:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eTherapeutic Approaches to the Difficult Patient\u003c\/strong\u003e\u003cbr\u003eStephen Stahl, MD, PhD, DSc (Hon)\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:15-5:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePanel Discussion #2\u003c\/strong\u003e\u003cbr\u003eRoscoe Brady, MD; Alejandro (Danny) Mendoza, MD; Stephen Stahl, MD, PhD, DSc (Hon)\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--title field field--name-field-hms-pdl-title field--type-string field--label-hidden field__items\"\u003e\n\u003ch4 class=\"field__item\"\u003eSaturday, March 29, 2025\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--items field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 hms-program-details-list--term\"\u003eDay Two\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:30-9:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eTreatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities\u003c\/strong\u003e\u003cbr\u003eMatcheri Keshavan, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:15-10:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eNeurobiology and Treatment of Sleep in Psychiatric Disorders\u003c\/strong\u003e\u003cbr\u003eJohn Winkelman, MD; Tony Cunningham, PhD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:15-10:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30-11:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eUpdate: Digital Phenotyping in Psychiatry and Psychopharmacology; Role of AI?\u003c\/strong\u003e\u003cbr\u003eJohn Torous, MD, MBI\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:15 AM-12:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eClinical Use for Psychedelics? Use for PTSD?\u003c\/strong\u003e\u003cbr\u003eRyan Henner, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:00-12:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePanel Discussion #1\u003c\/strong\u003e\u003cbr\u003eCarl Salzman, MD; John Torous, MD, MBI; John Winkelman, MD; Ryan Henner, MD; Tony Cunningham, PhD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:45-1:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eLunch \u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45-2:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eUpdate: Effective Treatment of Substance Use Disorders\u003c\/strong\u003e\u003cbr\u003eKevin Hill, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:30-3:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eTreatment of Anxiety Spectrum Disorders, and PTSD, New Benzodiazepine Data\u003c\/strong\u003e\u003cbr\u003eCarl Salzman, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:15-3:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:30-4:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePsychopharmacology of Trauma Related Disorders\u003c\/strong\u003e\u003cbr\u003eCharles Nemeroff, MD, PhD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:15-4:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003ePanel Discussion #2\u003c\/strong\u003e\u003cbr\u003eCarl Salzman, MD; Charles Nemeroff, MD, PhD; Matcheri Keshavan, MD; Kevin Hill, MD\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:45-5:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cstrong\u003eWrap-Up, Last Questions\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954475536482,"sku":"MED-AMB04120","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Screenshot-2025-04-17-224225.jpg?v=1779377453","url":"https:\/\/meducourse.com\/products\/harvard-psychopharmacology-2025-a-master-class","provider":"Meducourse","version":"1.0","type":"link"}